Phillip Gutry

Phillip Gutry

Keine laufenden Positionen mehr
52 Jahre
Health Technology
Finance
Consumer Services

Profil

Phillip P.
Gutry
worked as a Director of Corporate Development at Gilead Sciences, Inc. from 2006 to 2011.
He then worked as a Principal at MPM BioImpact, Inc. from 2011 to 2015.
From 2015 to 2018, he was an Executive Director of Business Development at Regeneron Pharmaceuticals, Inc. He also served as a Director at Potenza Therapeutics, Inc. and Amphivena Therapeutics, Inc. Additionally, he was an Independent Director at Avalo Therapeutics, Inc. from 2015 to 2021.
From 2018 to 2020, he was the Chief Business Officer at Kronos Bio, Inc. and later served as the CFO, Chief Business & Accounting Officer at Graphite Bio, Inc. Mr. Gutry received his undergraduate degree from Dartmouth College and his MBA from The Wharton School of the University of Pennsylvania.

Ehemalige bekannte Positionen von Phillip Gutry

UnternehmenPositionEnde
AVALO THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.11.2021
KRONOS BIO, INC. Corporate Officer/Principal 01.10.2020
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 01.10.2018
Private Equity Investor 01.06.2015
GILEAD SCIENCES, INC. Corporate Officer/Principal 01.05.2011
Sehen Sie sich die Erfahrung von Phillip Gutry im Detail an

Ausbildung von Phillip Gutry

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

64

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Services

Finance

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Phillip Gutry
LETZTE CHANCE | -40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT